N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144148 |
| CAS No | NA |
| Mol.F. | C18H19FN6O2 |
| Mol.Wt. | 370.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144149 |
| CAS No | NA |
| Mol.F. | C25H22F2N8O2 |
| Mol.Wt. | 504.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144150 |
| CAS No | NA |
| Mol.F. | C22H24FN3O5S |
| Mol.Wt. | 461.51 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0144151 |
| CAS No | NA |
| Mol.F. | C24H28FN3O5S |
| Mol.Wt. | 489.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144152 |
| CAS No | NA |
| Mol.F. | C22H22FN3O6S |
| Mol.Wt. | 475.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144153 |
| CAS No | NA |
| Mol.F. | C28H34FN3O7S |
| Mol.Wt. | 575.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144154 |
| CAS No | NA |
| Mol.F. | C30H30F3N3O6S |
| Mol.Wt. | 617.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144155 |
| CAS No | NA |
| Mol.F. | C29H36FN3O7S |
| Mol.Wt. | 589.68 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144156 |
| CAS No | NA |
| Mol.F. | C13H18FN3O |
| Mol.Wt. | 251.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144157 |
| CAS No | NA |
| Mol.F. | C25H33FN4O4 |
| Mol.Wt. | 472.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144158 |
| CAS No | NA |
| Mol.F. | C15H9BrF2N4O3 |
| Mol.Wt. | 411.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144159 |
| CAS No | NA |
| Mol.F. | C16H11BrF2N4O3 |
| Mol.Wt. | 425.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144160 |
| CAS No | NA |
| Mol.F. | C15H10BrF2N5O2 |
| Mol.Wt. | 410.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144161 |
| CAS No | NA |
| Mol.F. | C21H22BrF2N5O4 |
| Mol.Wt. | 526.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144162 |
| CAS No | NA |
| Mol.F. | C16H16BrF2N5O4 |
| Mol.Wt. | 460.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144163 |
| CAS No | NA |
| Mol.F. | C19H16BrF2N5O4 |
| Mol.Wt. | 496.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |